Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death

Sudhish Sharma, Rachana Mishra, Brandon L. Walker, Savitha Deshmukh, Manuela Zampino, Jay Patel, Mani Anamalai, David L. Simpson, Ishwar S. Singh, Shalesh Kaushal, Sunjay Kaushal

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Protein homeostatic regulators have been shown to ameliorate single, loss-of-function protein diseases but not to treat broader animal disease models that may involve cell death. Diseases often trigger protein homeostatic instability that disrupts the delicate balance of normal cellular viability. Furthermore, protein homeostatic regulators have been delivered invasively and not with simple oral administration. Here, we report the potent homeostatic abilities of celastrol to promote cell survival, decrease inflammation, and maintain cellular homeostasis in three different disease models of apoptosis and inflammation involving hepatocytes and cardiomyocytes. We show that celastrol significantly recovers the left ventricular function and myocardial remodeling following models of acute myocardial infarction and doxorubicin-induced cardiomyopathy by diminishing infarct size, apoptosis, and inflammation. Celastrol prevents acute liver dysfunction and promotes hepatocyte survival after toxic doses of thioacetamide. Finally, we show that heat shock response (HSR) is necessary and sufficient for the recovery abilities of celastrol. Our observations may have dramatic clinical implications to ameliorate entire disease processes even after cellular injury initiation by using an orally delivered HSR activator.

Original languageEnglish (US)
Pages (from-to)185-201
Number of pages17
JournalCell Stress and Chaperones
Volume20
Issue number1
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Animal Disease Models
Cell death
Shock
Animals
Cell Death
Hot Temperature
Heat-Shock Response
Ventricular Remodeling
Inflammation
Hepatocytes
Proteins
Thioacetamide
Apoptosis
Poisons
Cardiomyopathies
Left Ventricular Function
Cardiac Myocytes
Doxorubicin
Oral Administration
Liver Diseases

Keywords

  • Cardiomyopathy
  • Celastrol
  • Heat shock response
  • HSPs
  • Myocardial infarct

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Sharma, S., Mishra, R., Walker, B. L., Deshmukh, S., Zampino, M., Patel, J., ... Kaushal, S. (2015). Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death. Cell Stress and Chaperones, 20(1), 185-201. https://doi.org/10.1007/s12192-014-0536-1

Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death. / Sharma, Sudhish; Mishra, Rachana; Walker, Brandon L.; Deshmukh, Savitha; Zampino, Manuela; Patel, Jay; Anamalai, Mani; Simpson, David L.; Singh, Ishwar S.; Kaushal, Shalesh; Kaushal, Sunjay.

In: Cell Stress and Chaperones, Vol. 20, No. 1, 2015, p. 185-201.

Research output: Contribution to journalArticle

Sharma, S, Mishra, R, Walker, BL, Deshmukh, S, Zampino, M, Patel, J, Anamalai, M, Simpson, DL, Singh, IS, Kaushal, S & Kaushal, S 2015, 'Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death', Cell Stress and Chaperones, vol. 20, no. 1, pp. 185-201. https://doi.org/10.1007/s12192-014-0536-1
Sharma, Sudhish ; Mishra, Rachana ; Walker, Brandon L. ; Deshmukh, Savitha ; Zampino, Manuela ; Patel, Jay ; Anamalai, Mani ; Simpson, David L. ; Singh, Ishwar S. ; Kaushal, Shalesh ; Kaushal, Sunjay. / Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death. In: Cell Stress and Chaperones. 2015 ; Vol. 20, No. 1. pp. 185-201.
@article{f345c860cf6543a59c5b30a335a478dd,
title = "Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death",
abstract = "Protein homeostatic regulators have been shown to ameliorate single, loss-of-function protein diseases but not to treat broader animal disease models that may involve cell death. Diseases often trigger protein homeostatic instability that disrupts the delicate balance of normal cellular viability. Furthermore, protein homeostatic regulators have been delivered invasively and not with simple oral administration. Here, we report the potent homeostatic abilities of celastrol to promote cell survival, decrease inflammation, and maintain cellular homeostasis in three different disease models of apoptosis and inflammation involving hepatocytes and cardiomyocytes. We show that celastrol significantly recovers the left ventricular function and myocardial remodeling following models of acute myocardial infarction and doxorubicin-induced cardiomyopathy by diminishing infarct size, apoptosis, and inflammation. Celastrol prevents acute liver dysfunction and promotes hepatocyte survival after toxic doses of thioacetamide. Finally, we show that heat shock response (HSR) is necessary and sufficient for the recovery abilities of celastrol. Our observations may have dramatic clinical implications to ameliorate entire disease processes even after cellular injury initiation by using an orally delivered HSR activator.",
keywords = "Cardiomyopathy, Celastrol, Heat shock response, HSPs, Myocardial infarct",
author = "Sudhish Sharma and Rachana Mishra and Walker, {Brandon L.} and Savitha Deshmukh and Manuela Zampino and Jay Patel and Mani Anamalai and Simpson, {David L.} and Singh, {Ishwar S.} and Shalesh Kaushal and Sunjay Kaushal",
year = "2015",
doi = "10.1007/s12192-014-0536-1",
language = "English (US)",
volume = "20",
pages = "185--201",
journal = "Cell Stress and Chaperones",
issn = "1355-8145",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death

AU - Sharma, Sudhish

AU - Mishra, Rachana

AU - Walker, Brandon L.

AU - Deshmukh, Savitha

AU - Zampino, Manuela

AU - Patel, Jay

AU - Anamalai, Mani

AU - Simpson, David L.

AU - Singh, Ishwar S.

AU - Kaushal, Shalesh

AU - Kaushal, Sunjay

PY - 2015

Y1 - 2015

N2 - Protein homeostatic regulators have been shown to ameliorate single, loss-of-function protein diseases but not to treat broader animal disease models that may involve cell death. Diseases often trigger protein homeostatic instability that disrupts the delicate balance of normal cellular viability. Furthermore, protein homeostatic regulators have been delivered invasively and not with simple oral administration. Here, we report the potent homeostatic abilities of celastrol to promote cell survival, decrease inflammation, and maintain cellular homeostasis in three different disease models of apoptosis and inflammation involving hepatocytes and cardiomyocytes. We show that celastrol significantly recovers the left ventricular function and myocardial remodeling following models of acute myocardial infarction and doxorubicin-induced cardiomyopathy by diminishing infarct size, apoptosis, and inflammation. Celastrol prevents acute liver dysfunction and promotes hepatocyte survival after toxic doses of thioacetamide. Finally, we show that heat shock response (HSR) is necessary and sufficient for the recovery abilities of celastrol. Our observations may have dramatic clinical implications to ameliorate entire disease processes even after cellular injury initiation by using an orally delivered HSR activator.

AB - Protein homeostatic regulators have been shown to ameliorate single, loss-of-function protein diseases but not to treat broader animal disease models that may involve cell death. Diseases often trigger protein homeostatic instability that disrupts the delicate balance of normal cellular viability. Furthermore, protein homeostatic regulators have been delivered invasively and not with simple oral administration. Here, we report the potent homeostatic abilities of celastrol to promote cell survival, decrease inflammation, and maintain cellular homeostasis in three different disease models of apoptosis and inflammation involving hepatocytes and cardiomyocytes. We show that celastrol significantly recovers the left ventricular function and myocardial remodeling following models of acute myocardial infarction and doxorubicin-induced cardiomyopathy by diminishing infarct size, apoptosis, and inflammation. Celastrol prevents acute liver dysfunction and promotes hepatocyte survival after toxic doses of thioacetamide. Finally, we show that heat shock response (HSR) is necessary and sufficient for the recovery abilities of celastrol. Our observations may have dramatic clinical implications to ameliorate entire disease processes even after cellular injury initiation by using an orally delivered HSR activator.

KW - Cardiomyopathy

KW - Celastrol

KW - Heat shock response

KW - HSPs

KW - Myocardial infarct

UR - http://www.scopus.com/inward/record.url?scp=84914670576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914670576&partnerID=8YFLogxK

U2 - 10.1007/s12192-014-0536-1

DO - 10.1007/s12192-014-0536-1

M3 - Article

VL - 20

SP - 185

EP - 201

JO - Cell Stress and Chaperones

JF - Cell Stress and Chaperones

SN - 1355-8145

IS - 1

ER -